Sponsor Pipeline

Kriya Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-28 NCT07732400 A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
4
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07596485 RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal… Trigeminal Neuralgia Recruiting
NCT06765980 A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to… Geographic Atrophy Secondary to Age-related Macular Degeneration Recruiting
NCT07404111 A Study of VV-14305 for the Treatment of Thyroid Eye Disease Thyroid Eye Disease (TED) Not Yet Recruiting
NCT07732400 A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis… Metabolic Dysfunction-associated Steatohepatitis (MASH) Not Yet Recruiting
Disease Areas
Get alerts when Kriya Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free